Effects of Low-Dose Aspirin Therapy on Thermoregulation in Firefighters.
10.1016/j.shaw.2015.06.003
- Author:
Serina J MCENTIRE
1
;
Steven E REIS
;
Oscar E SUMAN
;
David HOSTLER
Author Information
1. Department of Exercise Physiology College of Nursing and Health Sciences, Valdosta State University, Valdosta, GA, USA. sjmcentire@valdosta.edu
- Publication Type:Randomized Controlled Trial ; Original Article
- Keywords:
aspirin;
exertion;
firefighter;
heat stress;
skin blood flow
- MeSH:
Arm;
Aspirin*;
Blood Platelets;
Body Temperature;
Body Temperature Regulation*;
Clothing;
Cross-Over Studies;
Firefighters*;
Fires;
Heart;
Heart Rate;
Hot Temperature;
Humans;
Humidity;
Laser-Doppler Flowmetry;
Skin;
Vasodilation
- From:Safety and Health at Work
2015;6(3):256-262
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Heart attack is the most common cause of line-of-duty death in the fire service. Daily aspirin therapy is a preventative measure used to reduce the morbidity of heart attacks but may decrease the ability to dissipate heat by reducing skin blood flow. METHODS: In this double-blind, placebo-controlled, crossover study, firefighters were randomized to receive 14 days of therapy (81-mg aspirin or placebo) before performing treadmill exercise in thermal-protective clothing in a hot room [38.8 +/- 2.1degrees C, 24.9 +/- 9.1% relative humidity (RH)]. Three weeks without therapy was provided before crossing to the other arm. Firefighters completed a baseline skin blood-flow assessment via laser Doppler flowmetry; skin was heated to 44degrees C to achieve maximal cutaneous vasodilation. Skin blood flow was measured before and after exercise in a hot room, and at 0 minutes, 10 minutes, 20 minutes, and 30 minutes of recovery under temperature conditions (25.3 +/- 1.2degrees C, 40.3 +/- 13.7% RH). Platelet clotting time was assessed before drug administration, and before and after exercise. RESULTS: Fifteen firefighters completed the study. Aspirin increased clotting time before and after exercise compared with placebo (p = 0.003). There were no differences in absolute skin blood flow between groups (p = 0.35). Following exercise, cutaneous vascular conductance (CVC) was 85 +/- 42% of maximum in the aspirin and 76 +/- 37% in the placebo groups. The percentage of maximal CVC did not differ by treatment before or after recovery. Neither maximal core body temperature nor heart rate responses to exercise differed between trials. CONCLUSION: There were no differences in skin blood flow during uncompensable heat stress following exercise after aspirin or placebo therapy.
